pnHIV (N = 14) | Control, historic from cardiac MRI lab (N = 26) | |
---|---|---|
Demographic and Clinical Data* | ||
Age (years) | 29.1 [27.7, 31.6] | 28.0 [25.0, 31.0] |
Female Sex | 10 (71.4%) | 17 (65.4%) |
Race | ||
Black/African-American | 12 (85.7%) | 22 (84.6%) |
White | 2 (14.3%) | 3 (11.5%) |
Unknown | 0 (0%) | 1 (3.8%) |
BMI (kg/m2) | 30.5 [24.5, 35.7] | 30.4 [23.7, 34.5] |
BSA (m2) | 1.8 [1.7, 2.0] | 1.9 [1.7, 2.1] |
Hypertension | 1 (7.1%) | 3 (11.5%) |
Missing | 0 | 0 |
Dyslipidemia | 0 (0%) | 1 (3.8%) |
Missing | 0 | 2 |
Diabetes Mellitus | 1 (7.1%) | 0 (0%) |
Missing | 0 | 1 |
Myocardial Infarction | 0 (0%) | 0 (0%) |
Missing | 0 | 1 |
NYHA Class | ||
NYHA Class I | 13 (92.9%) | -- |
NYHA Class II | 1 (7.1%) | -- |
Laboratory Data | ||
eGFR (mL/min) | 114.1 [92.3, 124.7] | 93.3 [87.4, 119.3] |
Missing | 1 | 3 |
CD4 count (cells/uL) | 632.5 [562.5, 1171.2] | -- |
Viral load (copies/mL) | 0.0 [0.0, 23.0] | -- |
Missing | 3 | -- |
LV Mass Index (g/m2) | 63.3 [54.8, 79.5] | -- |
Missing | 0 | -- |
Relative Wall Thickness (cm) | 0.4 [0.3, 0.4] | -- |
LVIDd (cm) | 4.5 [4.3, 4.7] | -- |
Calculated EF (%) | 58.0 [55.0, 60.0] | -- |
Missing (n) | 1 | -- |
E/A Ratio | 1.5 [1.4, 1.6] | -- |
E/E’ Ratio | 6.6 [6.0, 8.0] | -- |
Global Longitudinal Strain (%) | -18.1 [-19.2, -17.2] | -- |
CMR Data | ||
T1 Pre-Contrast (milliseconds) | 1230.1 [1220.1, 1242.9] | 1235.4 [1210.4, 1256.0] |
Missing | 1 | 0 |
Extracellular Volume (%) | 25.5 [24.1, 27.5] | 27.5 [23.7, 28.8] |
Missing | 1 | 0 |
LV End-Diastolic Volume (mL) | 139.7 [128.0, 147.0] | 127.8 [114.1, 156.0] |
Missing | 1 | 0 |
LV End-Systolic Volume (mL) | 58.8 [46.8, 60.8] | 49.7 [43.1, 66.2] |
Missing | 1 | 0 |
LV Ejection Fraction (%) | 58.4 [58.0, 63.8] | 61.3 [58.4, 63.0] |
Missing | 1 | 0 |
LV Cardiac Output (Liters/minute) | 5.6 [5.2, 6.0] | 5.8 [5.2, 6.3] |
Missing | 1 | 0 |
LV Mass (grams) | 96.5 [81.9, 104.7] | 102.0 [82.5, 132.7] |
Missing | 1 | 0 |